ozanimod,
RPC1063,
Ozanimod,
1306760-87-1,
Ozanimod (RPC1063),
RPC1063,
RPC-1063,
UNII-Z80293URPV,
Z80293URPV,
(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile,
Benzonitrile, 5-(3-((1S)-2,3-dihydro-1-((2-hydroxyethyl)amino)-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-(1-methylethoxy)-,
RPC1063;5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile,
Ozanimod [USAN:INN],
Benzonitrile, 5-[3-[(1S)-2,3-dihydro-1-[(2-hydroxyethyl)amino]-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-(1-methylethoxy)-,
RPC 1063,
ozanimod-rpc1063,
Ozanimod; RPC1063,
Ozanimod (USAN/INN),
GTPL8709,
SCHEMBL2195490,
CHEMBL3707247,
BCP16513,
EX-A1316,
RPC1063:RPC-1063,
MFCD28386168,
s7952,
AKOS026674086,
ZINC116109867,
ACN-037518,
CS-5070,
DB12612,
SB16927,
AC-29883,
HY-12288,
J3.612.016I,
D10968,
Ozanimod [INN],
C23-H24-N4-O3,
A15819,
5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile,